the clinical efficacy of terconazole ( triaconazole ) , a new triazole ketal structurally similar to ketoconazole , was evaluated in a single-blind , randomized comparative clinical trial including 60 patients with symptoms and clinical signs of vulvovaginal candidosis confirmed by microscopic examination and positive culture for candida albicans .
C0022625
ketoconazole
C0700345
vulvovaginal candidosis